Taken together, our data clearly illustrated that CMB suppressed HGSOC and NSCLC proliferation and cell cycle progression by targeting the MAPK pathway, p53/p21, and p53/Bax/Bcl-2 signaling pathways. Here, TP53 is linked to non-small cell lung carcinoma.